Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Minute Insight: Huma Buys AstraZeneca’s Amaze Digital Health Platform For Chronic Disease

Executive Summary

The companies will continue to collaborate to expand the reach of AstraZeneca's Amaze platform for chronic disease while launching companion applications.

You may also be interested in...



Minute Insight: Pear Therapeutics Inks Agreement With SoftBank To Develop Japan-Focused Digital Therapeutic

Pear Therapeutics signed an agreement with SoftBank to develop a Japan-focused digital therapeutic, but regulatory questions remain.

AstraZeneca’s Pangalos: Cultural Diversity Is Key To Educating Scientists

Mene Pangalos talked to Scrip about the importance of cultural diversity in a lab setting, pushing the frontiers on public-private partnerships and redoubling efforts on gene editing.

Digital Health Investment In India: Rearing Unicorns

Leaders from HealthQuad, the largest healthtech venture capital fund in India, talk to In Vivo about why the country is a growing and promising market for digital investment. 

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT145222

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel